Back
Adaptive Biotechnologies Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
ADPT
Adaptive Biotechnologies
Last Price:
$7.77
Seasonality Move:
14.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.45 | Buy |
| 20-day SMA: | 7.62 | Buy |
| 50-day SMA: | 7.84 | Sell |
| 200-day SMA: | 6.02 | Buy |
| 8-day EMA: | 7.62 | Buy |
| 20-day EMA: | 7.65 | Buy |
| 50-day EMA: | 7.62 | Buy |
| 200-day EMA: | 6.42 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 51.53 | Buy |
| Chaikin Money Flow: | -736657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.32 - 8.16) | Buy |
| Bollinger Bands (100): | (6.58 - 8.12) | Buy |
Adaptive Biotechnologies Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 7.77 while ADPT 8-day simple moving average is 7.45, which is a Buy signal.
-
The stock price of ADPT is 7.77 while Adaptive Biotechnologies 20-day SMA is 7.62, which makes it a Buy.
-
Adaptive Biotechnologies 50-day simple moving average is 7.84 while ADPT share price is 7.77, making it a Sell technically.
-
ADPT stock price is 7.77 and Adaptive Biotechnologies 200-day simple moving average is 6.02, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
63
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a BuyThe current Adaptive Biotechnologies [ADPT] share price is $7.77. The Score for ADPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
1.2B
Price in USD:
7.77
Share Volume:
1.1M
Adaptive Biotechnologies 52-Week Range
52-Week High:
9.01
52-Week Low:
2.56
Buy
63
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 7.77 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 7.77 while ADPT 8-day exponential moving average is 7.62, which is a Buy signal.
-
The stock price of ADPT is 7.77 while Adaptive Biotechnologies 20-day EMA is 7.65, which makes it a Buy.
-
Adaptive Biotechnologies 50-day exponential moving average is 7.62 while ADPT share price is 7.77, making it a Buy technically.
-
ADPT stock price is 7.77 and Adaptive Biotechnologies 200-day simple moving average is 6.42, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.19 per share, and an increase next year of $0.27 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Adaptive Biotechnologies is a Sell
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 51.53, which suggest Adaptive Biotechnologies is overbought
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (7.32 - 8.16), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (6.58 - 8.12), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.